CD22-targeted cytotoxin

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	moxetumomab pasudotox Sensitive: A1 - Approval moxetumomab pasudotox Sensitive : A1	moxetumomab pasudotox Sensitive: A1 - Approval moxetumomab pasudotox Sensitive : A1
CD22 positive	Lymphoma	CD22 positive	Lymphoma	moxetumomab pasudotox Sensitive: C2 – Inclusion Criteria moxetumomab pasudotox Sensitive : C2	moxetumomab pasudotox Sensitive: C2 – Inclusion Criteria moxetumomab pasudotox Sensitive : C2

Associations(2)